Evidence map›Paper›PMID 28351943›Full record

ArticleEndocrine-related cancer2017

Tahmineh Tabrizian, Donghai Wang, Fangxia Guan, Zunju Hu, Amanda P Beck, Fabien Delahaye, Derek M Huffman

Open access · bronzeAbstract read
In one paragraph

Article in Endocrine-related cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. The application of ApcJournal of cancer research and clinical oncology · 2019
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tahmineh TabrizianDepartment of Molecular PharmacologyAlbert Einstein College of Medicine, Bronx, New York, USA.
Donghai WangDepartment of Molecular PharmacologyAlbert Einstein College of Medicine, Bronx, New York, USA.
Fangxia GuanDepartment of Molecular PharmacologyAlbert Einstein College of Medicine, Bronx, New York, USA.
Zunju HuDepartment of Molecular PharmacologyAlbert Einstein College of Medicine, Bronx, New York, USA.
Amanda P BeckDepartment of Obstetrics & Gynecology and Women's HealthAlbert Einstein College of Medicine, Bronx, New York, USA.
Fabien DelahayeDepartment of GeneticsAlbert Einstein College of Medicine, Bronx, New York, USA.
Derek M HuffmanDepartment of Molecular PharmacologyAlbert Einstein College of Medicine, Bronx, New York, USA derek.huffman@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Einstein's Nathan Shock Center of Excellence in Basic Biology of AgingP30AG038072 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2010 to 2024
$10.8M
Training in Aging ResearchT32AG023475 · NIA · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI NIR J BARZILAI, DEREK Major HUFFMAN · 2004 to 2026
$8.6M
Peripheral and central IGF-1 action in energy balance and longevity modulation R00AG037574 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2013 to 2015
$732k
TNF alpha and IL-1 beta as pro-geronic factors in intestinal agingR56AG052981 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2016 to 2016
$459k
High-speed/resolution whole slide scanner supported by two core facilitiesS10OD019961 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2015 to 2015
$326k
NCI NIH HHS P30 CA013330NIA NIH HHS P30 AG038072NIA NIH HHS R00 AG037574NIA NIH HHS R56 AG052981NIA NIH HHS T32 AG023475NIDDK NIH HHS P30 DK020541NIH HHS S10 OD019961
6 · The paper itself

Abstract

Obesity is a major risk factor for colorectal cancer and can accelerate Lgr5+ intestinal stem cell (ISC)-derived tumorigenesis after the inactivation of

Indexed as

Adenomatous Polyposis Coli ProteinAnimalsCarcinogenesisDiet, Fat-RestrictedDiet, High-FatGastrointestinal TractGlucoseGreen Fluorescent ProteinsInsulinMaleMice, TransgenicObesityPTEN PhosphohydrolaseReceptors, G-Protein-CoupledStem CellsAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mouseGlucoseGreen Fluorescent ProteinsInsulinLgr5 protein, mousePTEN PhosphohydrolasePten protein, mouseReceptors, G-Protein-CoupledApccolon cancerLgr5obesityPten

Identifiers

PMID28351943
PMCPMC5505256
OpenAlexW2598446721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.